DV
Dividend Vision

EFTR — Effector Therapeutics Inc

Effector Therapeutics Inc (EFTR)

Total return is -100.0% over the past 5.5 years, 214.6 points behind SPY at 114.6%. Its deepest 1-year drawdown was 75.0%.

This is a single-stock equity fund that tracks Effector Therapeutics Inc, a biotechnology company. The fund does not currently pay distributions and has limited publicly available data on expense ratio and assets under management. This fund structure appeals primarily to investors seeking direct exposure to a specific biotech company's performance rather than traditional dividend income.

EFTR key facts

Asset type
Stock
Asset class
Equity
Inception date
03/01/2021
Last close
$0.0002
Market cap
$2,822
Average volume
127.0
Beta
2.383
Payout ratio
0.0
Forward P/E
0.0
EPS
$-15.08